CLOSING THE GOLDEN HOUR: IMPLEMENTATION AND COMPLIANCE OF THE SSC-2021

Sepsis is a life-threatening emergency associated with high mortality, and delays in initiating time-critical interventions directly worsen patient outcomes, prolong ICU admissions, and extend length of stay. Prior to this quality improvement initiative, the Department of General Medicine lacked a structured mechanism to verify compliance with the Surviving Sepsis Campaign (SSC) 2021 One-Hour Bundle, which mandates serum lactate measurement, blood cultures prior to antibiotics, administration of broad-spectrum antibiotics, fluid resuscitation, vasopressor support where indicated, and documentation of time-zero, all within sixty minutes of sepsis recognition.

A retrospective baseline audit of 44 patients meeting sepsis criteria (September 1 to November 30, 2025) was conducted using a structured proforma aligned to SSC-2021. Findings revealed significant gaps: blood samples frequently reached the laboratory late due to limited staff awareness of downstream consequences; antibiotics were often delayed beyond the one-hour window because of delayed investigation reports and procurement bottlenecks; documentation of arrival time, fluid bolus timing, and vasopressor initiation was inconsistent, making true compliance difficult to assess; serum lactate was not sent routinely, risking under-recognition of occult hypoperfusion; and ICU transfers frequently exceeded the recommended six-hour window. The existing data collection tool itself did not fully capture bundle-relevant timestamps. Collectively, these gaps resulted in poor overall compliance with the one-hour bundle, establishing the case for a focused corrective and re-audit cycle.

The aim was to reduce morbidity and mortality among suspected sepsis patients by ensuring timely, complete implementation of the SSC-2021 one-hour sepsis bundle. Specific objectives were to: assess baseline compliance with each bundle component; identify root causes of implementation delay; design and roll out focused corrective and educational interventions; re-evaluate compliance through a prospective re-audit; and identify residual gaps to guide the next quality improvement cycle. The target was full (100%) compliance across all measurable bundle components, evaluated across two defined periods — a baseline audit (September–November 2025, n=44) and a post-intervention re-audit (January 1–February 5, 2026, n=24) — covering sepsis patients presenting to the emergency room, wards, and ICU, excluding palliative care and DNR cases.

A two-stage audit-reaudit design was adopted: a retrospective baseline audit followed by a prospective, focused re-audit. Both stages used a structured audit proforma mapped to SSC-2021 bundle elements, capturing time of recognition, laboratory turnaround, antibiotic and fluid administration times, vasopressor use, and ICU transfer timelines, sourced from the Medical Records Department. The audit was led by the Professor of General Medicine as audit head, supported by a senior resident as audit person and ward in-charge nursing staff, ensuring departmental leadership ownership throughout.

Following baseline gap identification, a Corrective and Preventive Action (CAPA) plan was implemented: staff sensitization sessions on the clinical consequences of delay, reinforcement of time-zero documentation discipline, explicit emphasis on not deferring antibiotic administration pending investigations, and improved inter-departmental coordination for early treatment initiation. Preventive measures embedded into routine workflow included mandatory inclusion of lactate orders in the sepsis protocol, use of arterial blood gas (ABG) analysis as an interim lactate measurement route, and monthly compliance monitoring with continuous staff education to sustain gains.

The prospective re-audit (January 1–February 5, 2026; n=24), evaluated against the same SSC-2021 standard, demonstrated substantial improvement over the September–November 2025 baseline (n=44). Time-zero documentation improved from poor/inconsistent to 100%. Blood cultures obtained before antibiotic administration rose from delayed/inconsistent to 96%. Antibiotics administered within the one-hour window improved from delayed to 100%. Appropriately indicated IV fluid resuscitation reached 100%, and vasopressor use, previously poorly documented, was appropriate in all applicable cases. Overall complete one-hour bundle compliance rose from a low baseline rate to 100% post-intervention, evaluated over an approximately five-week re-audit window. The single persistent gap was serum lactate measurement, which remained at 0% due to non-availability of the lactate assay during the re-audit period rather than a process failure — an infrastructural constraint rather than a clinical-practice gap.

Beyond the numerical gains, the audit strengthened real-time clinical decision-making around sepsis recognition, reinforced accountability for time-critical documentation, and improved coordination between the Emergency Room, wards, and ICU, with direct implications for reduced mortality risk and improved patient safety culture.

Key challenges included variable staff awareness of how delays at any single step (sample dispatch, procurement, documentation) cascade into overall bundle failure; inconsistent baseline documentation practices that complicated accurate measurement of true compliance; and a persistent infrastructural constraint — non-availability of the serum lactate assay — that could not be resolved through process change alone. Coordinating timely ICU transfer within the recommended window also required inter-departmental alignment beyond the audit team’s direct control.

Critical success factors included direct leadership involvement, with the audit led by the Professor of General Medicine, lending authority and departmental ownership to the corrective actions. A structured, SSC-2021-aligned proforma ensured standardized, comparable data across both audit cycles. Targeted staff sensitization addressed the specific behavioral drivers of delay rather than generic awareness messaging. Embedding preventive actions (mandatory lactate ordering, ABG as an interim measure, monthly monitoring) into routine workflow, rather than as one-time corrections, supported sustainability of the gains achieved.

This audit-reaudit cycle demonstrates the institution’s capability to run a complete, evidence-based PDSA cycle — from baseline measurement through targeted intervention to verified re-audit — a core expectation for NABH accreditation readiness. Achieving 100% compliance across five of six bundle components confirms the effectiveness of leadership-driven, staff-focused corrective action rather than documentation alone. The persistent lactate-testing gap is an important accreditation signal: it highlights a diagnostic infrastructure limitation that must be escalated for resolution, since sustained compliance ultimately depends on availability of enabling resources, not process discipline alone. The audit also validates the value of embedding a standardized, bundle-aligned data collection tool as a permanent departmental fixture. For accreditation purposes, this case study evidences a functioning closed-loop quality improvement system with defined ownership, measurable targets, and a documented plan (March 2026 re-audit) for continued monitoring toward full compliance.